bendamustine hydrochloride has been researched along with B-Cell Leukemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, JR; Danilov, AV; Gordon, MJ; Lewis, LD | 1 |
Awan, FT; Costa, LJ; Gao, L; Gore, L; Lager, J; Sharma, J | 1 |
Albiero, E; Bernardi, M; Castegnaro, S; Chieregato, K; Madeo, D; Rodeghiero, F; Visco, C; Zanon, C | 1 |
1 review(s) available for bendamustine hydrochloride and B-Cell Leukemia
Article | Year |
---|---|
Bendamustine hydrochloride in patients with B-cell malignancies who have comorbidities - is there an optimal dose?
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Clinical Trials as Topic; Comorbidity; Humans; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Treatment Outcome | 2017 |
1 trial(s) available for bendamustine hydrochloride and B-Cell Leukemia
Article | Year |
---|---|
Phase Ib trial of the PI3K/mTOR inhibitor voxtalisib (SAR245409) in combination with chemoimmunotherapy in patients with relapsed or refractory B-cell malignancies.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Drug Administration Schedule; Drug Monitoring; Drug Resistance, Neoplasm; Female; Humans; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Maximum Tolerated Dose; Middle Aged; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Recurrence; Retreatment; Rituximab; Sulfonamides; TOR Serine-Threonine Kinases; Treatment Outcome | 2016 |
1 other study(ies) available for bendamustine hydrochloride and B-Cell Leukemia
Article | Year |
---|---|
Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Bendamustine Hydrochloride; Cell Cycle; Cell Line, Tumor; Cytarabine; Humans; Leukemia; Leukemia, B-Cell; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Nitrogen Mustard Compounds | 2012 |